Goldman Sachs is in talks to buy a large group of company stakes being sold by asset manager Invesco as it looks to shift illiquid holdings whose value has been hit by the COVID-19 disease outbreak, Sky News reported citing sources.
The holdings are valued at several hundred million pounds, the report said.
A unit of Goldman Sachs Asset Management is close to buying the stakes, which include a holding in Oxford Nanopore, a gene sequencing specialist, according to the report.
Some of the collection of private company holdings were assembled by Neil Woodford, whose flagship fund was winded down last year following a four-and-a-half month suspension, that marked a stunning reversal of fortune for one of Britain’s most high profile investors.
Representatives at Goldman Sachs and Invesco declined to comment.
Source: Reuters.com